Porto-based PFx Biotech introduced right this moment that it has closed a €2.5 million Seed funding spherical to advance its precision fermentation platform for producing bioidentical human milk proteins – aiming to ship sustainable, non-GMO, and allergy-free dietary options for all life levels.
The spherical was led by Buenavista Fairness Companions alongside EIT Meals and Beta Capital. This coincides with a latest €2.5 million grant from the EIC Accelerator, which is able to permit PFx Biotech to additional scale up the manufacturing of Lactoferrin to pre-industrial ranges, set up its personal bespoke labs, and develop the crew.
“This can be a defining second for PFx Biotech,” mentioned Ali Osman, Founder and CEO of PFx Biotech. “We’re proud to be backed by mission – aligned traders to assist us unlock the potential of Lactoferrin in a extra sustainable vitamin mannequin. As we enter this new development stage, we’re actively exploring strategic collaborations throughout R&D, scale-up, and go-to-market alternatives.”
Based in 2022, PFx Biotech is creating an engineering biology platform to supply extremely bioactive human milk proteins through a scalable precision fermentation course of, to be used within the superior vitamin markets.
Their crew brings expertise in dairy proteins, fermentation, molecular biology, scale up and open innovation, rooted in sustainability.
PFx Biotech’s engineering biology-based platform for the large-scale manufacturing of useful components, together with human milk proteins, might be formulated into client merchandise starting from toddler method, sports activities vitamin and aged vitamin merchandise.
Human milk proteins are the golden dietary and health-promoting proteins in formative years vitamin. By producing extremely bioactive various human milk proteins, by precision fermentation, PFx is reportedly creating a brand new class of components that can help and enhance the immune system.
Past new technology toddler method, their non-allergenic, GMO-, dairy- and animal-free proteins are simply digestible and bioavailable, making them ideally suited for all populations, together with these with particular dietary wants, specifically aged and athletes.
“We imagine PFx Biotech is likely one of the few firms with the scientific depth, technical execution, and visionary management required to make precision fermentation commercially viable at scale,” mentioned Bibi Sattar Marques, Companion at Buenavista Fairness Companions. “This funding displays our conviction in biology-driven options to reshape the meals system and our confidence within the PFx crew to steer that change.”
At a time when precision fermentation is rising as a cornerstone know-how for sustainable, nutritious, and resilient meals techniques, this twin achievement locations the PFx Biotech in an excellent place to additional its developments on this area.
“We’re not solely pushed by the pressing want of taking severe steps in direction of disrupting the present proteins manufacturing techniques, but in addition enthusiastic about our mission to positively impression the lifetime of hundreds of thousands,” added PFx Biotech.
